Best Doctors for Robotic Surgery in Delhi NCR, India

Dr. Yajvender Pratap Singh Rana is a Senior Director of Urology, Uro-Oncology, Andrology and Kidney Transplant at BLK-Max Super Speciality Hospital in New Delhi, one of India's most prestigious healthcare institutions. He holds an MBBS, MS in General Surgery, and DNB in Genito Urinary Surgery, bringing 14+ years of clinical expertise to complex urological and transplant cases. Dr. Rana has performed thousands of uro-oncology procedures, including robotic radical prostatectomy and advanced robotic surgical interventions. His clinical depth spans cancer-related urological surgeries, reconstructive urology, laparoscopic urology, andrology, endourology, and renal care technology. He is recognised for his surgical proficiency, particularly in living-donor and deceased-donor kidney transplantation, as well as minimally invasive stone and prostate interventions. His international exposure includes an observership at the prestigious Johns Hopkins Brady Urological Institute in Baltimore, USA, which has enriched his surgical perspective and technical skills. Dr. Rana welcomes international patients from the Gulf region, Africa, and across South Asia, offering comprehensive urological and transplant services. His experience treating cross-border patients and fluency in English and Hindi ensure clear communication and culturally sensitive care. He has been honoured with awards including a Gold Medal from the National Board of Examination for 1st rank in Urology, as well as recognition at national and international urology conferences. BLK-Max Super Speciality Hospital, where Dr. Rana practices, is a leading multi-specialty institution with advanced robotic and endoscopic facilities, a robust transplant programme, and dedicated international patient support. The hospital's NABH accreditation and comprehensive ICU capacity make it a preferred destination for complex urological and transplant cases. International patients benefit from a dedicated international patient desk, visa assistance, and coordination of pre- and post-operative care. Dr. Rana's combination of technical expertise and international experience makes him a trusted choice for patients seeking advanced urological treatment outside their home country.

Dr. Akshat Malik is a Senior Consultant in Surgical Oncology specialising in Head & Neck cancer surgery at Indraprastha Apollo Hospital, New Delhi. With over 13 years of focused clinical experience, he holds impressive international qualifications including FRCS from the Royal College of Surgeons, England, and FACS from the American College of Surgeons. His expertise spans the full spectrum of head and neck malignancies, from oral cavity and pharyngeal cancers to laryngeal, thyroid, and salivary gland tumours. Dr. Malik has performed over 3,000 head and neck cancer surgeries, combining oncologic precision with functional and cosmetic preservation. He is a certified robotic console surgeon with specialised expertise in scarless robotic thyroidectomy and transoral robotic surgery (TORS), enabling effective cancer removal with superior cosmetic and functional outcomes. His approach emphasises preserving speech, swallowing, and appearance while ensuring optimal cancer control. He has published over 50 PubMed-indexed research papers in leading international oncology journals and contributed chapters to authoritative textbooks in Head & Neck Oncology, demonstrating his commitment to evidence-based practice. Dr. Malik treats a significant international patient population, including patients from the Gulf Cooperation Council countries, North Africa, and across South Asia. International patients appreciate his fluency in English, his alignment with global oncology guidelines, and his ability to deliver complex reconstructive surgery with minimal morbidity. He combines Indian surgical precision with international standards of care, making him a trusted choice for patients seeking world-standard cancer treatment close to home. Indraprastha Apollo Hospital in New Delhi is a Joint Commission International (JCI)-accredited tertiary-care centre with state-of-the-art surgical facilities, including dedicated robotic operating theatres and comprehensive head and neck oncology infrastructure. The hospital has a well-established international patient services desk, multilingual support, and seamless coordination for medical tourism. Dr. Malik's practice benefits from Apollo's strengths in imaging, pathology, critical care, and post-operative rehabilitation, ensuring comprehensive cancer care aligned with international protocols. International patients choosing Dr. Malik gain access to advanced surgical oncology at a fraction of costs in Western countries, with the added assurance of internationally recognised qualifications and memberships in ASCO, BAHNO, and the Foundation of Head & Neck Oncology. His commitment to functional outcomes makes him particularly suited for patients prioritising quality of life alongside cancer cure.

Dr. Sushil Kumar Jain is an Additional Director of Surgical Oncology at Fortis Memorial Research Institute in Gurugram, with over 12 years of specialist experience in cancer surgery. He holds an MBBS, MS in General Surgery, DNB in Surgical Oncology, and completed advanced robotic surgery training at Manipal University. His credentials span internationally recognized training programmes in robotic oncology at Florida Hospital, USA, and Yonsei University Hospital, Seoul, South Korea. This diverse training background has made him a comprehensive surgical oncologist with deep expertise across multiple cancer types. Dr. Jain has successfully completed more than 4,000 complex oncological operations using open, laparoscopic, and robotic approaches. His clinical strengths include breast-conserving surgery, oncoplastic breast reconstruction, sentinel lymph node biopsy, head and neck cancer resections including Trans Oral Robotic Surgery (TORS), robotic colorectal and thoracic oncology, and hepato-biliary and pancreatic cancer surgery. He combines oncological principles with reconstructive techniques to optimise both cancer control and quality of life for his patients. His meticulous approach to surgical margins and lymph node assessment reflects current international standards in oncologic practice. Dr. Jain regularly treats international patients from the Gulf region, Africa, and South Asian countries seeking advanced cancer care in India. He understands the specific needs of medical tourists and works closely with Gaf Healthcare to coordinate consultations, pre-operative workup, and post-operative follow-up across borders. His fluency in English and Hindi facilitates clear communication with diverse patient populations. Many patients from the Middle East and beyond choose his care for complex breast and gastrointestinal malignancies where both oncologic control and aesthetic or functional outcomes matter. Fortis Memorial Research Institute is one of India's leading cancer and multi-specialty research hospitals, accredited by NABH and equipped with state-of-the-art robotic surgery suites, advanced imaging, and dedicated oncology ICU facilities. The hospital's strong international patient services team, combined with its robust clinical research culture, makes it an ideal destination for international patients seeking expert oncological care. The institution's commitment to evidence-based practice aligns well with Dr. Jain's clinical philosophy. International patients should know that Dr. Jain offers both in-person and video consultations through Gaf Healthcare, allowing initial assessment and treatment planning before travel. The typical hospital stay for major oncological surgery ranges from 5–7 days, with regular virtual follow-up consultations available post-discharge. His extensive publication record and award-winning conference presentations demonstrate an ongoing commitment to advancing cancer care and sharing knowledge with the global surgical oncology community.

Dr. Swati Nair is an Associate Consultant in Head & Neck Surgical Oncology at Medanta — The Medicity, Gurgaon, bringing over 10 years of specialized surgical expertise to the management of head and neck cancers. She holds an MBBS from Kasturba Medical College, Mangalore, an MS in ENT from B R Ambedkar Medical College, Bangalore, and a dedicated Fellowship in Head & Neck Surgical Oncology from Medanta, Gurugram. Her clinical foundation is built on rigorous training at a high-volume head and neck cancer centre, equipping her with the precision and depth required for complex oncologic cases. Dr. Nair's surgical portfolio is extensive and evidence-based. She has assisted and performed over 800 thyroidectomies and 400 oral cancer surgeries, demonstrating significant clinical volume in her core areas. Her expertise spans oral cancer surgery, thyroid and parathyroid oncology, comprehensive neck dissections, salivary gland surgery, and oropharyngeal and hypopharyngeal malignancies. She employs advanced techniques including sentinel lymph node biopsy protocols, composite resections for complex tumours, and transoral robotic approaches where appropriate, ensuring personalised surgical planning for each patient. International patients from the Gulf region, Africa, and South Asia comprise a meaningful portion of her case load at Medanta. Dr. Nair combines technical excellence with a patient-centred approach, taking time to explain surgical options and expected outcomes to patients from diverse backgrounds. Her commitment to multidisciplinary care ensures coordination with medical oncology, radiation therapy, and rehabilitation teams, addressing the holistic needs of cancer patients. Medanta — The Medicity is a NABH and JCI-accredited tertiary-care facility in Gurgaon, known for its dedicated Cancer Care department and comprehensive oncologic support infrastructure. The hospital's robust international patient services, in-house diagnostics, and coordinated care model make it an ideal destination for complex head and neck malignancies. International patients benefit from streamlined admission processes, English-speaking nursing staff, and proximity to Delhi's international airport, reducing logistical burden during treatment and recovery.